Track Every Presidential Action. Understand the Impact.

Regulatory Relief To Promote Domestic Production of Critical Medicines

President Donald Trump issued Executive Order 14293 on May 5, 2025, to streamline regulations and promote domestic production of critical medicines. The order directs the Food and Drug Administration (FDA) and other agencies to review and eliminate unnecessary regulations that hinder the development of pharmaceutical manufacturing in the United States. It aims to reduce the time and complexity involved in building and expanding pharmaceutical facilities by addressing regulatory barriers, enhancing inspection processes, and improving coordination among agencies. The goal is to make the U.S. a more competitive environment for producing safe and effective medicines, thereby strengthening national security and ensuring a resilient supply chain.